Cargando…

Ferroptosis of epithelial ovarian cancer: genetic determinants and therapeutic potential

Epithelial ovarian cancer (OVCA) is the most lethal gynecologic cancer. Current treatment for OVCA involves surgical debulking of the tumors followed by combination chemotherapies. While most patients achieve complete remission, many OVCA will recur and develop chemo-resistance. Whereas recurrent OV...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Chao-Chieh, Chi, Jen-Tsan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2020
Materias:	Research Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533070/ https://www.ncbi.nlm.nih.gov/pubmed/33062192 http://dx.doi.org/10.18632/oncotarget.27749

Ejemplares similares

Environmental Determinants of Ferroptosis in Cancer
por: Setayeshpour, Yasaman, et al.
Publicado: (2023)

Regulation of ferroptosis in cancer cells by YAP/TAZ and Hippo pathways: The therapeutic implications
por: Sun, Tianai, et al.
Publicado: (2020)

Ferroptosis in epithelial ovarian cancer: a burgeoning target with extraordinary therapeutic potential
por: Ruan, Danhua, et al.
Publicado: (2023)

Zinc transporter ZIP7 is a novel determinant of ferroptosis
por: Chen, Po-Han, et al.
Publicado: (2021)

Genetic alterations and their therapeutic implications in epithelial ovarian cancer
por: Lapke, Nina, et al.
Publicado: (2021)

Opportunities for Ferroptosis in Cancer Therapy
por: Fujihara, Kenji M., et al.
Publicado: (2021)

The Intersection of DNA Damage Response and Ferroptosis—A Rationale for Combination Therapeutics
por: Chen, Po-Han, et al.
Publicado: (2020)

Editorial: Novel Insights Into Ferroptosis
por: Setayeshpour, Yasaman, et al.
Publicado: (2021)

Regulation of mammalian target of rapamycin on ferroptosis: from mechanism to therapeutics in septic cardiomyopathy
por: Zhao, Guoyu, et al.
Publicado: (2022)

CXC Chemokine Signaling in Progression of Epithelial Ovarian Cancer: Theranostic Perspectives
por: Huang, Xinxin, et al.
Publicado: (2022)

The regulation of ferroptosis by MESH1 through the activation of the integrative stress response
por: Lin, Chao-Chieh, et al.
Publicado: (2021)

Mitochondrial regulation of ferroptosis
por: Gan, Boyi
Publicado: (2021)

Unexpected zinc dependency of ferroptosis: what is in a name?
por: Chen, Po-Han, et al.
Publicado: (2021)

A joint analysis of metabolomics and genetics of breast cancer
por: Tang, Xiaohu, et al.
Publicado: (2014)

Ferroptosis in Ovarian Cancer: A Novel Therapeutic Strategy
por: Li, Lanyu, et al.
Publicado: (2021)

FBXO45 is a potential therapeutic target for cancer therapy
por: Lin, Min, et al.
Publicado: (2020)

Conceptualizing the complexity of ferroptosis to treat triple-negative breast cancer: theory-to-practice
por: Zhang, Hang, et al.
Publicado: (2023)

Genetic analysis of potential biomarkers and therapeutic targets in ferroptosis from psoriasis
por: Wu, Man-Ning, et al.
Publicado: (2023)

SARS-CoV-2 infection: can ferroptosis be a potential treatment target for multiple organ involvement?
por: Yang, Ming, et al.
Publicado: (2020)

Genetically Engineered Cellular Membrane Vesicles as Tailorable Shells for Therapeutics
por: Ren, En, et al.
Publicado: (2021)

Ferroptosis: copper-iron connection in cuprizone-induced demyelination
por: Jhelum, Priya, et al.
Publicado: (2021)

Iron regulatory protein 1: the deadly switch of ferroptosis
por: Bórquez, Daniel A., et al.
Publicado: (2023)

Comprehensive Analysis Identifies Potential Ferroptosis-Associated mRNA Therapeutic Targets in Ovarian Cancer
por: Zhang, Jiyan, et al.
Publicado: (2021)

Loss of ferritin in developing wing cells: Apoptosis and ferroptosis coincide
por: Hernández-Gallardo, Anna Karen, et al.
Publicado: (2020)

Study of Ferroptosis Transmission by Small Extracellular Vesicles in Epithelial Ovarian Cancer Cells
por: Alarcón-Veleiro, Carmen, et al.
Publicado: (2023)

Epigenetic and genetic dispositions of ovarian carcinomas
por: Yamaguchi, Ken, et al.
Publicado: (2014)

The therapeutic potential of targeting the EGFR family in epithelial ovarian cancer
por: Sheng, Q, et al.
Publicado: (2011)

The emerging roles and therapeutic potential of exosomes in epithelial ovarian cancer
por: Li, Xiaoduan, et al.
Publicado: (2017)

Mutational Screening of BRCA1/2 Genes as a Predictive Factor for Therapeutic Response in Epithelial Ovarian Cancer: A Consensus Guide from the Spanish Society of Pathology (SEAP-IAP) and the Spanish Society of Human Genetics (AEGH)
por: Palacios, J., et al.
Publicado: (2019)

Genetic basis of kidney cancer: Role of genomics for the development of disease-based therapeutics
por: Linehan, W. Marston
Publicado: (2012)

Ferroptosis in Intracerebral Hemorrhage: A Panoramic Perspective of the Metabolism, Mechanism and Theranostics
por: Lu, Chenxiao, et al.
Publicado: (2022)

miR-124, a potential therapeutic target in colorectal cancer
por: Qin, Zhen, et al.
Publicado: (2019)

Lycium barbarum polysaccharides and ferroptosis: jumping into the era of novel regulated cell death
por: Lo, Amy Cheuk Yin, et al.
Publicado: (2021)

Ferroptosis and glaucoma: implications in retinal ganglion cell damage and optic nerve survival
por: Yang, Ming, et al.
Publicado: (2022)

Therapeutic potential of stem cells in orthopedics
por: Bahney, Chelsea Shields, et al.
Publicado: (2012)

Clinical Efficacy of Ovarian Cancer Screening
por: Koshiyama, Masafumi, et al.
Publicado: (2016)

Engineering Ferroptosis Inhibitors as Inhalable Nanomedicines for the Highly Efficient Treatment of Idiopathic Pulmonary Fibrosis
por: Guo, Mengqin, et al.
Publicado: (2023)

Therapeutic strategies in epithelial ovarian cancer
por: Kim, Ayako, et al.
Publicado: (2012)

Glutamine Synthetase Is a Genetic Determinant of Cell Type–Specific Glutamine Independence in Breast Epithelia
por: Kung, Hsiu-Ni, et al.
Publicado: (2011)

The Expanding Therapeutic Potential of Neuronal KCC2
por: Tang, Bor Luen
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mc93nrc3op9s5hi2ckhmkhujmc